Company Filing History:
4 out of 3,923 
1 out of 1 Years Active: 2018-2025
Title: The Innovative Contributions of Elisabete Goncalves
Introduction
Elisabete Goncalves is a notable inventor based in Basel, Switzerland. She has made significant contributions to the field of pharmaceutical formulations, particularly in the development of tablet formulations for cancer treatment. With a total of 4 patents to her name, her work has the potential to impact the lives of many patients.
Latest Patents
Goncalves' latest patents include a tablet formulation of 2-fluoro-N-methyl-4-[7-(quinolin-6-ylmethyl)imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide. This invention relates to tablets that comprise this compound, detailing processes for their production and their uses in treating certain cancers. The formulation aims to provide effective treatment options for patients suffering from these diseases.
Career Highlights
Throughout her career, Elisabete Goncalves has worked with prominent companies in the pharmaceutical industry, including Novartis AG and Debiopharma SA. Her experience in these organizations has allowed her to refine her skills and contribute to groundbreaking research in drug formulation.
Collaborations
Goncalves has collaborated with esteemed colleagues such as Shau-Fong Yen and Sudha Vippagunta. These partnerships have fostered an environment of innovation and have led to the successful development of her patented formulations.
Conclusion
Elisabete Goncalves stands out as a dedicated inventor whose work in pharmaceutical formulations is paving the way for advancements in cancer treatment. Her contributions are invaluable, and her patents reflect her commitment to improving patient care.